Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease

References

• Jenner P. Oxidative stress as a cause of Parkinson's disease. Acta Neurol Scand Suppl 1991; 136: 6–15
   PubMedGoogle Scholar
• Fahn S, Cohen G. The oxidant stress hypothesis in Parkinson's disease: Evidence supporting it. Ann Neurol 1992; 32: 804–812
   PubMed Web of Science ®Google Scholar
• Dexter DT, Carter CJ, Wells FR, Javoy-Agid F, Agid Y, Lees A, Jenner P, Marsden CD. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J Neurochem 1989; 52: 381–389
   PubMed Web of Science ®Google Scholar
• Sofic E, Lange KW, Jellinger K, Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci Lett 1992; 142: 128–130
   PubMed Web of Science ®Google Scholar
• Saggu H, Cooksey J, Dexter DT, Wells FR, Lees A, Jenner P, Marsden CD. A selective increase in particulate superoxide dismutase activity in parkinsonian substantia nigra. J Neurochem 1989; 53(1989)692–697
   PubMedGoogle Scholar
• Dexter DT, Wells FR, Agid F, Agid Y, Lees AJ, Jenner P, Marsden CD. Increased nigral iron content in postmortem parkinsonian brain. Lancet 1987; 2: 1219–1220
   PubMed Web of Science ®Google Scholar
• Kuhnan J. The flavonoids. A class of semi-essential food components: Their role in human nutrition. World Rev Nutr Diet 1976; 24: 117–119
   PubMedGoogle Scholar
• Hertog HGL, Hollman PCH, Katan MB, Kromhout D. Intake of potentially anticarcinogenic flavonoids and their determinants in adults in Netherlands. Nutr Cancer 1993; 20: 21–29
   PubMed Web of Science ®Google Scholar
• Vinson JA, Jang J, Dabbagh JA, Serry MM, Cai S. Plant flavonoids, especially tea flavonoids, are powerful antioxidants using an in vitro oxidation model for heart disease. J Agric Food Chem 1995; 43: 2800–2802
   Web of Science ®Google Scholar
• Wiseman SA, Balentine DA, Frei B. Antioxidants in tea. Crit Rev Food Sci Nutr 1997; 37: 705–718
   PubMed Web of Science ®Google Scholar
• Saija A, Scalese M, Lanza M, Marzullo D, Bonia F, Caselli F. Flavonoids as antioxidant agents: Importance of their interaction with biomembranes. Free Radic Biol Med 1995; 19(1995)481–486
   PubMedGoogle Scholar
• Middleton E, Kandaswami C, Theoharides T. The effect of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev 2000; 52: 673–751
   PubMed Web of Science ®Google Scholar
• Sudheesh S, Sandhya C, Koshy S, Vijayalakshmi NR. Antioxidant activity of flavonoids from Solanum melongena. Phytother Res 1999; 13: 393–396
   PubMed Web of Science ®Google Scholar
• Park YC, Rimbach G, Saliou C, Valacchi S, Parker L. Activity of monomeric, dimeric and trimeric flavonoids on NO production, TNF secretion and NF-kB dependent gene expression in RAW 264.7 macrophages. FEBS Lett 1999; 465: 93–97
   Web of Science ®Google Scholar
• Hoult JR, Moroney MA, Paya M. Actions of flavonoids and coumarins on lipoxygenase and cyclooxygenase. Methods Enzymol 1994; 234: 443–454
   PubMed Web of Science ®Google Scholar
• Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG, Shin DH. Effect of antioxidant flavonone, naringenin, from Citrus junos on neuroprotection. J Agric Food Chem 2004; 52: 1520–1525
   PubMed Web of Science ®Google Scholar
• Ganguli M, Chandra V, Kamboh MI, Johnston JM, Dodge HH, Thelma BK, Juyal RC, Pandav R, Belle SH, De-Kosky ST. Apolipoprotein E polymorphism and Alzheimer's disease: The Indo-US cross-national Dementia study. Arch Neurol 2000; 57: 824–830
   PubMed Web of Science ®Google Scholar
• Robak R, Gryglewski RJ. Flavonoids are scavengers of superoxide anions. Biochem Pharmacol 1988; 37: 837–841
   PubMed Web of Science ®Google Scholar
• Muthane U, Yasha TC, Shankar SK. Low numbers and no loss of melanized nigral neurons with increasing age in normal human brains from India. Ann Neurol 1998; 43: 283–287
   PubMed Web of Science ®Google Scholar
• Chang WS, Lee YJ, Lu FJ, Chiang HC. Inhibitory effects of flavonoids on xanthine oxidase. Anticancer Res 1993; 13: 2165–2170
   PubMed Web of Science ®Google Scholar
• van Acker S, van den Berg D, Tromp MN, Griffioen DH, van Bennekom WP, van der Vijgh WJF, Bast A. Structural aspects of antioxidant activity of flavonoids. Free Radic Biol Med 1996; 20: 331–342
   PubMed Web of Science ®Google Scholar
• Datla KP, Christidou M, Widmer WW, Rooprai HK, Dexter DT. Tissue distribution and neuroprotective effects of citrus flavonoid tangeretin in a rat model of Parkinson's disease. Neuroreport 2001; 12: 3871–3875
   PubMed Web of Science ®Google Scholar
• Paxinos G, Watson C. The rat brain in sterotaxic coordinates2nd ed. Academic Press, London 1986
   Google Scholar
• Carman LS, Gage FH, Shults CW. Partial lesion of the substantia nigra: Relation between extent of lesion and rotational behaviour. Brain Res 1991; 553: 275–283
   PubMed Web of Science ®Google Scholar
• Datla KP, Blunt SB, Dexter DT. Chronic L-DOPA administration is not toxic to the remaining dopaminergic nigrostriatal neurons, but instead may promote their functional recovery, in rats with partial 6-OHDA or FeCl3 nigrostriatal lesions. Mov Disord 2001; 16: 424–434
   PubMed Web of Science ®Google Scholar
• Ungerstedt U. 6-hydroxydopamine induced degeneration of central monoamine neurons. Eur J Pharmacol 1968; 5: 107–110
   PubMed Web of Science ®Google Scholar
• Jeon BS, Jackson-Lewis V, Burke RE. 6-OHDA lesion of the rat substantia nigra: Time course and morphology of cell death. Neurodegeneration 1995; 4: 131–137
   PubMedGoogle Scholar
• Cohen G, Heikkila RE. The generation of hydrogen peroxide, superoxide radical and hydroxyl radical by 6-hydroxydopamine, dialuric acid and related cytotoxic agents. J Biol Chem 1974; 249: 2447–2452
   PubMed Web of Science ®Google Scholar
• Sachs CH, Jonsson G. Mechanism of action of 6-hydroxydopamine. Pharmacology 1975; 24(1975)1–8
   Google Scholar
• Levites Y, Youdim MBH, Maor G, Mandel S. Attenuation of 6-hydroxydopamine (6-OHDA)-induced nuclear factor-kappa B (NF-kB) activation and cell death by tea extracts in neuronal cultures. Biochem Pharmacol 2002; 63: 21–29
   PubMed Web of Science ®Google Scholar
• Nie G, Jin C, Cao Y, Shen S, Zhao B. Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch Biochem Biophys 2002; 397: 84–90
   PubMed Web of Science ®Google Scholar
• Datla KP, Bennett RD, Zbarsky V, Ke B, Liang YF, Higa T, Bahorun T, Aruoma OI, Dexter DT. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease. J Pharm Pharmacol 2004; 56: 649–654
   PubMed Web of Science ®Google Scholar
• Kunchandy E, Rao MNA. Oxygen radical scavenging activity of curcumin. Int J Pharm 1990; 58: 237–240
   Web of Science ®Google Scholar
• Awasthi S, Srivastava SK, Piper JT, Singhal SS, Chaubey M, Awasthi YC. Curcumin protects against 4-hydroxy-2-trans-nonenal-induced cataract formation in rat lenses. Am J Clin Nutr 1996; 64: 761–766
   PubMed Web of Science ®Google Scholar
• Srivastava R, Srima RC. Modification of certain inflammation induced biochemical changes by curcumin. Indian J Med Res 1985; 81: 215–223
   PubMed Web of Science ®Google Scholar
• Chang MMY. Inhibition of tumor necrosis factor by curcumin, a phytochemical. Biochem Pharmacol 1995; 45(1995)1551–1556
   Google Scholar
• Daniel S, Limson JL, Dairam A, Watkins GM, Daya S. Through metal binding, curcumin protects against lead- and cadmium-induced lipid peroxidation in rat brain homogenates and against lead-induced tissue damage in rat brain. J Inorg Biochem 2004; 98: 266–275
   PubMed Web of Science ®Google Scholar
• Reddy AC, Lokesh BR. Studies on the inhibitory effects of curcumin and eugenic on the formation of reactive oxygen species and the oxidation of ferrous iron. Mol Cell Biochem 1994; 17: 1–8
   Google Scholar
• Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ. Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicalism. Cell Biophys 1989; 14: 175–185
   PubMedGoogle Scholar
• Martin-Aragon S, Benedi JM, Villar AM. Modifications on antioxidant capacity and lipid peroxidation in mice under fraxetin treatment. J Pharm Pharmacol 1997; 49: 49–52
   PubMed Web of Science ®Google Scholar
• Xu YX, Pindolia KR, Janakiraman N, Chapman RA, Gautam SC. Gautam, Curcumin inhibits IL-1 alpha and TNF-alpha induction of AP-1 and NK-kB DNA-binding activity in bone marrow stromal cells. Hematopathol Mol Hematol 1998; 11: 49–62
   Google Scholar
• Chan MM, Huang HI, Fenton MR, Fong D. In vivo inhibition of nitric oxide synthase gene expression by curcumin, a cancer preventive natural product with anti-inflammatory properties. Biochem Pharmacol 1998; 55: 1955–1962
   PubMed Web of Science ®Google Scholar
• Zhang F, Altorki NK, Mestre JR, Subbaramaiah K, Dannenberg AJ. Curcumin inhibits cyclooxygenase-2 transcription in bile acid- and phorbol ester-treated human gastrointestinal epithelial cells. Carcinogenesis 1999; 20: 445–451
   PubMed Web of Science ®Google Scholar
• Iqbal M, Sharma SD, Okazaki Y, Fujisawa M, Okada S. Dietary supplementation of curcumin enhances antioxidant and phase II metabolizing enzymes in ddY male mice: Possible role in protection against chemical carcinogenesis and toxicity. Pharmacol Toxicol 2003; 92: 33–38
   PubMedGoogle Scholar
• Shukla PK, Khanna VK, Khan MY, Srimal RC. Srimal, Protective effect of curcumin against lead neurotoxicity in rat. Hum Exp Toxicol 2003; 22: 653–658
   PubMed Web of Science ®Google Scholar
• Kim DS, Park SY, Kim JK. Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from beta A (1–42) insult. Neurosci Lett 2001; 303: 57–61
   PubMed Web of Science ®Google Scholar
• Ono K, Hasegawa K, Naiki H, Yamada M. Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J Neurosci Res 2004; 75: 742–750
   PubMed Web of Science ®Google Scholar
• Fraustchy SA, Hu W, Kim P, Miller SA, Chu T, Harris-White ME, Cole GM. Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol Aging 2001; 22: 993–1005
   PubMed Web of Science ®Google Scholar
• Lim GP, Chu T, Yang F, Beech W, Frautschy SA, Cole GM. The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J Neurosci 2001; 21: 8370–8377
   PubMed Web of Science ®Google Scholar
• Vajragupta O, Boochoong P, Watanabe H, Tohda M, Kummasud N, Sumanont Y. Manganese complexes of curcumin and its derivatives; evaluation for the radical scavenging ability and neuroprotective activity. Free Radic Biol Med 2003; 35: 1632–1644
   PubMed Web of Science ®Google Scholar
• Kelloff GJ, Crowell JA, Hawk ET. Strategy and planning for chemopreventive drug development: clinical development plans II. J Cell Biochem Suppl 1996; 26: 54–71
   PubMedGoogle Scholar
• Chainani-Wu N. Safety and anti-Inflammatory activity of curcumin: A Component of Tumeric (Curcuma longa). J Altern Complement Med 2003; 9: 161–168
   PubMed Web of Science ®Google Scholar
• Srimal RC, Dhawan BN. Pharmacology of diferuloyl methane (curcumin), a non-steroidal anti-inflammatory agent. J Pharm Pharmacol 1973; 25: 447–452
   PubMed Web of Science ®Google Scholar
• Heo HJ, Kim DO, Shin SC, Kim MJ, Kim BG, Shin DH. Effect of antioxidant flavonone, naringenin, from Citrus junos on neuroprotection. J Agric Food Chem, 52(2004)1520–1525
   PubMedGoogle Scholar
• Cheng F, Breen K. On the ability of four flavonoids, baicilein, luteolin, naringenin and quercetin, to suppress the Fenton reaction of the iron ATP complex. Biometals 2000; 13: 77–83
   PubMed Web of Science ®Google Scholar
• Jeon SM, Bok SH, Jang MK, Lee MK, Nam KT, Park YB, Rhee SJ, Choi MS. Antioxidative activity of naringin and lovastatin in high cholesterol-fed rabbits. Life Sci 2001; 69: 855–866
   PubMed Web of Science ®Google Scholar
• Lee MK, Bok SH, Jeong TS, Moon SS, Lee SE, Park YB, Choi MS. Supplementation of naringenin and its synthetic derivative alters antioxidant enzyme activities of erythrocyte and liver in high cholesterol-fed rats. Bioorg Med Chem 2002; 10: 2239–2244
   PubMed Web of Science ®Google Scholar
• van Acker FA, Schouten O, Haenen GR, van der Vijgh WJF, Bast A. Flavonoids can replace α-tocopherol as an antioxidant. FEBS Lett 2000; 473: 145–148
   PubMed Web of Science ®Google Scholar
• Tsai TH. Determination of naringin in rat blood, brain, liver, and bile using microdialysis and its interaction with cyclosporine A, a P-glycoprotein modulator. J Agric Food Chem 2002; 50: 6669–6674
   PubMed Web of Science ®Google Scholar
• Youdim KA, Dobbie MS, Kuhnle G, Proteggente AR, Abbott NJ, Rice-Evans C. Interaction between flavonoids and the blood-brain barrier: in vitro studies. J Neurochem 2003; 85: 180–192
   PubMed Web of Science ®Google Scholar
• Peng HW, Cheng FC, Huang YT, Chen CF, Tsai TH. Determination of naringenin and its glucuronide conjugate in rat plasma and brain tissue by high-performance liquid chromatography. Chromatogr B Biomed Sci Appl 1998; 714: 369–374
   PubMed Web of Science ®Google Scholar
• Youdim KA, Qaiser MZ, Begley DJ, Rice-Evans CA, Abbott NJ. Flavonoid permeability across an in situ model of the blood-brain barrier. Free Radic Biol Med 2004; 36: 592–604
   PubMed Web of Science ®Google Scholar
• Manach C, Donovan J. Pharmacokinetics and Metabolism of dietary flavonoids. Free Rad Res 2004; 38: 771–785
   PubMed Web of Science ®Google Scholar